Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00004139

Public ClinicalTrials.gov record NCT00004139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 14, 2026, 7:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Randomized Trial of Gemcitabine/Docetaxel and Gemcitabine/Irinotecan in Stage IIIB/IV Non-Small Cell Lung Cancer

Study identification

NCT ID: NCT00004139
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Enrollment: 80 participants

Conditions and interventions

Conditions

Lung Cancer

Interventions

docetaxel Drug
gemcitabine hydrochloride Drug
irinotecan hydrochloride Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 1999
Primary completion: Jun 30, 2004
Completion: Dec 31, 2005
Last update posted: Jul 19, 2016

1999 – 2006

United States locations

U.S. sites: 8
U.S. states: 6
U.S. cities: 7

Facility	City	State	ZIP	Site status
Vincent T. Lombardi Cancer Research Center, Georgetown University	Washington D.C.	District of Columbia	20007	—
Walter Reed Army Medical Center	Washington D.C.	District of Columbia	20307-5000	—
Barnes-Jewish Hospital	St Louis	Missouri	63110	—
CCOP - Southern Nevada Cancer Research Foundation	Las Vegas	Nevada	89106	—
Duke Comprehensive Cancer Center	Durham	North Carolina	27710	—
Medical University of South Carolina	Charleston	South Carolina	29425-0721	—
CCOP - Greenville	Greenville	South Carolina	29615	—
University of Tennessee, Memphis Cancer Center	Memphis	Tennessee	38163	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00004139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 19, 2016 · Synced May 14, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →